Navigation Links
CPhI India and Co-Located Events Offer Diverse Programme to Support the Growing Indian Pharma Market

AMSTERDAM, Oct. 18, 2011 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced details of CPhI India and its co-located events, which will be hosted from 30th November to 2nd December, 2011 at the Bombay Exhibition Centre in Mumbai, India. Focused on pharmaceutical ingredients, CPhI India will be joined by co-located events: P-MEC India for pharmaceutical equipment, machinery and technology; ICSE India for contract services, clinical trials; and CRO and the BioPh trail for the biopharma market. Catering to all sectors in the pharma industry, both domestic and international, UBM Live's cluster of India-focused events offer attendees a dedicated platform to network with key decision makers in the Indian pharmaceutical industry, connect with existing  partners and make new contacts. In 2010 the events hosted over 26,400 visitors and over 800 exhibiting companies, figures that UBM Live expects to be exceed this year.

Continuing UBM Live's commitment to developing and evolving value-add initiatives for visitors and exhibitors around its Indian events, the CPhI India Conference Series will return in 2011. Introduced in 2010 to positive feedback, the series programme will cover a selection of key trends and topics pertinent to the Indian and South Asian pharmaceuticals markets, including: Global Clinical Trials; Global Biosimilars Regulations; Healthcare and OTC Drugs; Developing Difficult Generics; Export Potential; and Competitive API Strategies.  The conference series will feature high level speakers from respected companies such as Sanofi-Aventis, GlaxoSmithKline, Pfizer, and Dr. Reddy's Laboratories.

"Mirroring the increasing importance of the Indian pharmaceutical market, CPhI India and co-located events have been built around a unique programme based on consultation and feedback from visitors and exhibitors," commented Annemieke Timmers, Brand Director CPhI. "We have geared the show to deliver significant return on investment (ROI) for pharma professionals who are currently working with or looking to establish relationships with Indian pharmaceutical companies.  Our events offer direct access to a high-growth market that is estimated to generate US $13.1 Billion revenue in FY 2011(1). Beyond the immediate projections for the market, the domestic pharmaceutical industry in India is expected to further grow at a compounded annual growth rate (CAGR) of around 15% during FY 2012-FY 2014(2).  Our visitors are guaranteed to benefit from strengthening current business relations and making new business connections in a market that is well equipped to scale-up to requests for products and services quickly through networks that take advantage of the latest technologies available."

CPhI India and P-MEC India are the largest and most comprehensive pharma industry events in South Asia and have gained a reputation as the 'must attend' events in this market. Additionally, ICSE India has quickly gained a positive reputation in the market by offering direct access to the outsourcing and contract services sector which is one of the fastest growing segments within the Indian pharmaceutical industry, and weekly pre-registrations are currently running over 300% higher than they were at the same time in 2010.

UBM Live's market leading annual schedule of pharma brands includes CPhI for pharmaceutical ingredients, ICSE for contract services and outsourcing, P-MEC Europe for pharmaceutical equipment, machinery and technology, InnoPack for innovative packaging concepts in the pharmaceutical packaging market, and BioPh for the biopharmaceuticals market. Co-located annual events include Worldwide (25-27, October, Messe Frankfurt, Germany 2011), Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Center, Japan) China (26-28 June, 2012, SNIEC, Shanghai, China), and South America (21-23 August, 2012, Transamerica Expo Centre, Brazil).

(1) RNCOS, India Pharma Sector Forecast 2014

(2) RNCOS, India Pharma Industry Set to Take Off in Near Future

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
3. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
4. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
5. International Diabetes Federation Grant Supports Lifestyle Intervention Study to Prevent Type 2 Diabetes in India
6. Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
7. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
8. Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
9. Life Sciences Company Opens Clinical Trial Bridge to India
10. Pioneering Brain Malformation Treatment Performed Using Novalis Tx(TM) Radiosurgery Technology in India
11. Reportlinker Adds Medical Devices & Equipment in India (2009)
Post Your Comments:
(Date:12/1/2015)... 1, 2015  Eyeon Therapeutics has received a ... treatments based on a charged hydrophilic polymer developed ... The product has been shown to be safe ... Mark Mitchnick , MD, CEO states, "This ... additional polymers in conjunction with a therapeutic agent.  ...
(Date:12/1/2015)... 1, 2015  Athletic apparel company Tommie ... to pay $1.35 million to settle Federal Trade ... copper-infused compression clothing would relieve severe and chronic ... diseases. Tommie Copper,s proposed ... and its founder and chairman Thomas Kallish ...
(Date:12/1/2015)... diciembre de 2015  AccuTEC Blades, una ... precisión, develó hoy un nuevo logo corporativo ... El nuevo logo destaca la experiencia de ... de productos con cuchillas donde "el borde ... --> ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... ... The Multiple System Atrophy Coalition has announced the launch of its MSA Can’t ... today to coincide with Giving Tuesday 2015, a global day of fundraising. , ... be productive, to do simple daily activities like walking to the mailbox and eating ...
(Date:12/1/2015)... ... December 01, 2015 , ... Royal River Natural Foods — a locally-owned, ... post-menopausal women who took the nutritional supplement creatine, along with resistance training for a ... not take creatine. , The report is part of the December 2015 issue of ...
(Date:12/1/2015)... ... 2015 , ... Baptist Medical Center Jacksonville has implanted the ... hospital in the region providing what is known as the world’s smallest pacemaker. ... revealed recently at a medical conference and published in The New England Journal ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... to continue the expansion of the company’s growing product line of food safety ... (Oncorhynchus tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... the United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of ... often catastrophic contributors to diseases of the diabetic foot. The American Board ...
Breaking Medicine News(10 mins):